YLB’s phase III clinical trial of Etanercept biosimilar meets positive outcome
The study was a multinational randomised double-blind controlled trial of 52 weeks duration which included more than 500 patients…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
A sustainable future with green chemistry
Nitesh H Mehta, Co-Founder Director, Newreka Green-Synth Technologies and Krishna B Padia, Executive Director, Green ChemisTree…
CDSS market in India to reach 206.1 million dollars
According to the new BIS Research report, the spread of this technology to other markets and geographies in India will be driven…
Melanoma sales projected to rise to $5.5 bn dollars in 2026
According to GlobalData, there will be nearly 207,000 cases of melanoma in 2026, rising from nearly 166,000 in 2016
Global glaucoma market to reach $3.8 bn by 2026
The growth will be driven by the launch of pipeline products
The NAMO Effect
The Namo government has not really wooed the pharma sector in it's first tenure. Despite some significant measures, the industry…
HC restrains ex-Ranbaxy promoters from selling assets till Feb 26
The court also directed the brothers and 12 others, including their family members and companies, to come up with a plan on how…
DRL’s Chairman, COO added as defendants in US lawsuit
The lawsuit filed at the District Court for New Jersey seeks damages to compensate the class of investors for a 'purported…
NATCO Pharma undergoes API facility inspection by US FDA
The regulatory audit resulted in zero observations and no Form 483 was issued